Way2VAT (ASX:W2V) - Unlocking a US$239bn Market with AI-Powered Tax

Preview text: Way2VAT (ASX:W2V) - Unlocking a US$239bn Market with AI-Powered Tax 96 From single-product…

Tuesday, Aug 25, 2026 at 10:21 PM EasternHubSpot

SharewiseWay2VAT (ASX:W2V) - Unlocking a US$239bn Market with AI-Powered Tax

Fit to screenFull size

Using this email in an article? Credit: Sharewise email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: Way2VAT (ASX:W2V) - Unlocking a US$239bn Market with AI-Powered Tax
Preview text: Way2VAT (ASX:W2V) - Unlocking a US$239bn Market with AI-Powered Tax 96 From single-product…
From: enquiries@sharewise.com.au
Brand: Sharewise
ESP: HubSpot
Sent: Tue Aug 25, 2026, 10:21 PM ET
Size: 65 KB
Images: 9
Links: 13, 1 of them buttons
Subject length: 67 characters

Against Sharewise's usual

Sent in the 10 PM hour, which holds 11% of its emails; 16% arrive in the 9 PM hour. The subject is 67 characters; its average is 56.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Sharewise <[email protected]>
Reply-To: [email protected]
Subject: Way2VAT (ASX:W2V) - Unlocking a US$239bn Market with AI-Powered Tax
Date: Wed, 26 Aug 2026 12:21:12 +1000
Message-ID domain: bf05x.hubspotemail.net
Return-Path domain: bf05x.hubspotemail.net
DKIM signature: d=bf05x.hubspotemail.net s=hs2; d=sharewise.com.au s=hs1-24076189
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Aug 26, 2026 9:48 PM	Join Our Webinar with GG1 CEO Quentin Hill!
	Aug 26, 2026 9:18 PM	Oneview (ASX:ONE, Valuation A$0.28/shr, +75% upside) - Quality over Quantity
	Aug 26, 2026 12:54 AM	Join Our Webinar with SCX.ai Holdings!
	Aug 25, 2026 10:21 PM	Way2VAT (ASX:W2V) - Unlocking a US$239bn Market with AI-Powered Tax (this email)
	Aug 20, 2026 10:22 PM	Join Our DC Cooling Webinar with Experts!
	Aug 20, 2026 2:42 AM	Watch Complii's Webinar with Craig Mason Now!
	Aug 19, 2026 2:19 AM	Join Our Webinar with Alterity Therapeutics CEO!